| 12194032 |
Method of treating focal segmental glomerulosclerosis |
Zhenhua Miao, Rajinder Singh |
2025-01-14 |
|
| 11883391 |
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies |
James J. CAMPBELL, Israel Charo, Rajinder Singh, Yibin Zeng, Penglie Zhang |
2024-01-30 |
|
| 11844790 |
Methods of treating hidradenitis suppurativa |
Shijie LI, Rajinder Singh, Peter Staehr |
2023-12-19 |
|
| 11744822 |
Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors |
Israel Charo, Heiyoun Jung, Penglie Zhang |
2023-09-05 |
|
| 11382915 |
Treatment of focal segmental glomerulosclerosis with CCR2 antagonists |
Zhenhua Miao, Rajinder Singh |
2022-07-12 |
$22,229,000 |
| 11324736 |
Method of Treating Focal Segmental Glomerulosclerosis |
Zhenhua Miao, Rajinder Singh |
2022-05-10 |
$31,479,000 |
| 11304952 |
Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor |
James J. CAMPBELL, Zhenhua Miao, Israel Charo, Shijie LI, Christine Janson +2 more |
2022-04-19 |
$47,084,000 |
| 11045469 |
Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies |
James J. CAMPBELL, Israel Charo |
2021-06-29 |
$20,821,000 |
| 11020394 |
Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C—C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies |
Yibin Zeng, Penglie Zhang, Israel Charo, James J. CAMPBELL |
2021-06-01 |
$15,330,000 |
| 10973809 |
Method of treating focal segmental glomerulosclerosis |
Zhenhua Miao, Rajinder Singh |
2021-04-13 |
$36,366,000 |
| 10792360 |
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies |
James J. CAMPBELL |
2020-10-06 |
$280,385,000 |
| 10758540 |
Treatment of focal segmental glomerulosclerosis with CCR2 antagonists |
Zhenhua Miao, Rajinder Singh |
2020-09-01 |
$83,153,000 |
| 10568870 |
Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors |
Israel Charo, Heiyoun Jung, Penglie Zhang |
2020-02-25 |
$97,821,000 |
| 8642808 |
Bis-aryl sulfonamides |
Solomon Ungashe, Zheng Wei, John J. Wright, Andrew Pennell, Brett Permack |
2014-02-04 |
$3,780,000 |
| 8637043 |
Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
Zhenhua Miao, Robert Berahovich, Zheng Wei, Maureen Howard, Brett Premack |
2014-01-28 |
$3,874,000 |
| 8343492 |
Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies |
Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Albert Zlotnik |
2013-01-01 |
|
| 7871619 |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
Jennifer M. Burns, Bretton Summers, Maureen Howard, Zhenhua Miao |
2011-01-18 |
|
| 7785804 |
Mammalian CX3C chemokine antibodies |
Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Albert Zlotnik |
2010-08-31 |
|
| 7777009 |
Compositions for detecting and treating diseases and conditions related to chemokine receptors |
Jennifer M. Burns, Bretton Summers, Maureen Howard |
2010-08-17 |
|
| 7741519 |
Bis-aryl sulfonamides |
Solomon Ungashe, Zheng Wei, John J. Wright, Andrew Pennell, Brett Permack |
2010-06-22 |
|
| 7678891 |
Antibodies that bind CCX-CKR2 |
Maureen Howard |
2010-03-16 |
|
| 7649011 |
Inhibitors of human tumor-expressed CCXCKR2 |
Anita Melikian, Jennifer M. Burns, Brian E. McMaster, J.J. Wright |
2010-01-19 |
|
| 7585502 |
Mammalian CX3C chemokine antibodies |
Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Albert Zlotnik |
2009-09-08 |
$139,526,000 |
| 7572600 |
Enzymatic activities in chemokine-mediated inflammation |
Robert Berahovich, Zhenhua Miao, Brett Premack |
2009-08-11 |
|
| 7442512 |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
Jennifer M. Burns, Zhenhua Miao, Zheng Wei, Maureen Howard, Brett Premack |
2008-10-28 |
|